|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cohen EE, Lingen MW and Vokes EE: The
expanding role of systemic therapy in head and neck cancer. J Clin
Oncol. 22:1743–1752. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2015. CA Cancer J Clin. 65:5–29. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kramer R, Shen X and Zhou H: Tumor cell
invasion and survival in head and neck cancer. Cancer Metastasis
Rev. 24:35–45. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ziober AF, Falls EM and Ziober BL: The
extracellular matrix in oral squamous cell carcinoma: Friend or
foe? Head Neck. 28:740–749. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
De Hert MJ and de Jong RJ Baatenburg: HGF
and c-MET as potential orchestrators of invasive growth in head and
neck squamous cell carcinoma. Front Biosci. 13:2516–2526. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kalyankrishna S and Grandis JR: Epidermal
growth factor receptor biology in head and neck cancer. J Clin
Oncol. 24:2666–2672. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Rorth P: Collective cell migration. Annu
Rev Cell Dev Biol. 25:407–429. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Neiva KG, Zhang Z, Miyazawa M, Warner KA,
Karl E and Nör JE: Cross talk initiated by endothelial cells
enhances migration and inhibits anoikis of squamous cell carcinoma
cells through STAT3/Akt/ERK signaling. Neoplasia. 11:583–593. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Friedl P and Wolf K: Plasticity of cell
migration: A multiscale tuning model. J Cell Biol. 188:11–19. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Seiwert TY, Jagadeeswaran R, Faoro L,
Janamanchi V, Nallasura V, El Dinali M, Yala S, Kanteti R, Cohen
EE, Lingen MW, et al: The MET receptor tyrosine kinase is a
potential novel therapeutic target for head and neck squamous cell
carcinoma. Cancer Res. 69:3021–3031. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bonner JA, Harari PM, Giralt J, Cohen RB,
Jones CU, Sur RK, Raben D, Baselga J, Spencer SA, Zhu J, et al:
Radiotherapy plus cetuximab for locoregionally advanced head and
neck cancer: 5-year survival data from a phase 3 randomised trial
and relation between cetuximab-induced rash and survival. Lancet
Oncol. 11:21–28. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fung C and Grandis JR: Emerging drugs to
treat squamous cell carcinomas of the head and neck. Expert Opin
Emerg Drugs. 15:355–373. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lemmon MA and Schlessinger J: Cell
signaling by receptor tyrosine kinases. Cell. 141:1117–1134. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jorissen RN, Walker F, Pouliot N, Garrett
TP, Ward CW and Burgess AW: Epidermal growth factor receptor:
Mechanisms of activation and signalling. Exp Cell Res. 284:31–53.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Laimer K, Spizzo G, Gastl G, Obrist P,
Brunhuber T, Fong D, Barbieri V, Jank S, Doppler W, Rasse M and
Norer B: High EGFR expression predicts poor prognosis in patients
with squamous cell carcinoma of the oral cavity and oropharynx: A
TMA-based immunohistochemical analysis. Oral Oncol. 43:193–198.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Citri A and Yarden Y: EGF-ERBB signalling:
Towards the systems level. Nat Rev Mol Cell Biol. 7:505–516. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Huang C, Jacobson K and Schaller MD: MAP
kinase and cell migration. J Cell Sci. 117:4619–4628. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bunney TD and Katan M: Phosphoinositide
signalling in cancer: Beyond PI3K and PTEN. Nat Rev Cancer.
10:342–352. 2010. View
Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kölsch V, Charest PG and Firtel RA: The
regulation of cell motility and chemotaxis by phospholipid
signaling. J Cell Sci. 121:551–559. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Irie HY, Pearline RV, Grueneberg D, Hsia
M, Ravichandran P, Kothari N, Natesan S and Brugge JS: Distinct
roles of Akt1 and Akt2 in regulating cell migration and
epithelial-mesenchymal transition. J Cell Biol. 171:1023–1034.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Loesch M and Chen G: The p38 MAPK stress
pathway as a tumor suppressor or more? Front Biosci. 13:3581–3593.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ye M, Hu D, Tu L, Zhou X, Lu F, Wen B, Wu
W, Lin Y, Zhou Z and Qu J: Involvement of PI3K/Akt signaling
pathway in hepatocyte growth factor-induced migration of uveal
melanoma cells. Invest Ophthalmol Vis Sci. 49:497–504. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Zuo JH, Zhu W, Li MY, Yi H, Zeng GQ, Wan
XX, He QY, Li JH, Qu JQ, Chen Y and Xiao ZQ: Activation of EGFR
promotes squamous carcinoma SCC10A cell migration and invasion via
inducing EMT-like phenotype change and MMP-9-mediated degradation
of E-cadherin. J Cell Biochem. 112:2508–2517. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wheeler SE, Suzuki S, Thomas SM, Sen M,
LeemanNeill RJ, Chiosea SI, Kuan CT, Bigner DD, Gooding WE, Lai SY
and Grandis JR: Epidermal growth factor variant III mediates head
and neck cancer cell invasion via STAT3 activation. Oncogene.
29:5135–5145. 2009. View Article : Google Scholar
|
|
26
|
Lin WL, Lin YS, Shi GY, Chang CF and Wu
HL: Lewisy promotes migration of oral cancer cells by glycosylation
of epidermal growth factor receptor. PLoS One. 10:e01201622015.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Holz C, Niehr F, Boyko M, Hristozova T,
Distel L, Budach V and Tinhofer I:
Epithelial-mesenchymal-transition induced by EGFR activation
interferes with cell migration and response to irradiation and
cetuximab in head and neck cancer cells. Radiother Oncol.
101:158–164. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Thomas SM, Bhola NE, Zhang Q, Contrucci
SC, Wentzel AL, Freilino ML, Gooding WE, Siegfried JM, Chan DC and
Grandis JR: Cross-talk between G protein-coupled receptor and
epidermal growth factor receptor signaling pathways contributes to
growth and invasion of head and neck squamous cell carcinoma.
Cancer Res. 66:11831–11839. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liebmann C: EGF receptor activation by
GPCRs: An universal pathway reveals different versions. Mol Cell
Endocrinol. 331:222–231. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Ohnishi Y, Yasui H, Kakudo K and Nozaki M:
Cetuximab-resistant oral squamous cell carcinoma cells become
sensitive in anchorage-independent culture conditions through the
activation of the EGFR/AKT pathway. Int J Oncol. 47:2165–2172.
2015.PubMed/NCBI
|
|
31
|
Pollard TD and Borisy GG: Cellular
motility driven by assembly and disassembly of actin filaments.
Cell. 112:453–465. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Wyckoff JB, Jones JG, Condeelis JS and
Segall JE: A critical step in metastasis: In vivo analysis of
intravasation at the primary tumor. Cancer Res. 60:2504–2511.
2000.PubMed/NCBI
|
|
33
|
Seppa H, Grotendorst G, Seppä S,
Schiffmann E and Martin GR: Platelet derived growth factor in
chemotactic for fibroblasts. J Cell Biol. 92:584–588. 1982.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Yip SC, ElSibai M, Coniglio SJ, Mouneimme
G, Eddy RJ, Drees BE, Neilsen PO, Goswami S, Symons M, Condeelis JS
and Backer JM: The distinct roles of Ras and Rac in PI
3-kinase-dependent protrusion during EGF-stimulated cell migration.
J Cell Sci. 120:3138–3146. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Barrientos J, Stojadinoric O, Golinko MS,
Brem H and Tomic-Canic M: Growth factors and cytokines in wound
healing. Wound Repair Regen. 16:585–601. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yue P, Zhang X, Paladino D, Sengupta B,
Ahmad S, Holloway RW, Ingersoll SB and Turkson J: Hyperactive EGFR
receptor, Jaks and Stat3 signaling promote enhanced colony-forming
ability, motility and migration of cisplatin-resistant ovarian
cancer cells. Oncogene. 31:2309–2322. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Liu SV, Subramaniam D, Cyriac GC,
AbdoulKhalek FJ and Giaccone G: Emberging protein kinase inhibitors
for non-small cell lung cancer. Expert Opin Emerg Drugs. 19:51–65.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Potratz J, Tillmanns A, Berning P,
Korsching E, Schaefer C, Lechtape B, Schleithoff C, Unland R,
Schäfer KL, Müller-Tidow C, et al: Receptor tyrosine kinase gene
expression profiles of Ewing sarcomas reveal ROR1 as a potential
therapeutic target in metastatic disease. Mol Oncol. 10:677–692.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Birchmeier C, Birchmeier W, Gherardi E and
Woude GF Vande: Met, metastasis, motility and more. Nat Rev Mol
Cell Biol. 4:915–925. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gherardi E, Birchmeier W, Birchmeier C and
Woude G Vande: Targeting MET in cancer: Rationale and progress. Nat
Rev Cancer. 12:89–103. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Penzes K, Baumann C, Szabadkai I, Orfi L,
Kéri G, Ullrich A and Torka R: Combined inhibition of AXL, Lyn and
p130Cas kinase block migration of triple negative breast cancer
cells. Cell Biol Ther. 15:1571–1582. 2014.
|
|
42
|
Sie M, den Dunne WF, Lourens HJ,
Meeuwsen-de Boer TG, Scherpen FJ, Zomerman WW, Kampen KR, Horing EW
and de Bant ES: Growth-factor-driven rescue to receptor tyrosine
kinase (RTK) inhibitors through Akt and Erk phosphorylation in
pediatric low grade astrocytoma and ependymoma. PLoS One.
10:e01225552015. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Favreau AJ, Vary CP, Brooks PC and
Sathyanarayana P: Cryptic collagen IV promotes cell migration and
adhesion in myeloid leukemia. Cancer Med. 3:265–272. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Small JV and Resch GP: The comings and
goings of actin: Coupling protrusion and retraction in cell
motility. Curr Opin Cell Biol. 17:517–523. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Kang F, Purich DL and Southwick FS:
Profilin promotes barbed-end actin filament assembly without
lowering the critical concentration. J Biol Chem. 274:36963–36972.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Konakahara S, Ohashi K, Mizuno K, Itoh K
and Tsuji T: CD29 integrin-β and LIMK1/cofilin-mediated actin
reorganization regulates the migration of haematopoietic progenitor
cells underneath bone marrow stromal cells. Genes Cells. 9:345–358.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Yun SP, Ryu JM, Jang MW and Han HJ:
Interaction of profiling-1 and F-actin via a β-arrestin-1/JNK
signaling pathway involved in prostaglandin E(2)-induced human
mesenchymal stem cells migration and proliferation. J Cell Physiol.
226:559–571. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Pantalon D and Carlier MF: How profiling
promotes actin filament assembly in the presence of thymosin beta
4. Cell. 75:1007–1014. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Kobayashi M, Nishita M, Mishima T, Ohashi
K and Mizuno K: MAPKAPK-2 mediated LIM-kinase activation is
critical for VEGF-induced actin remodeling and cell migration. EMBO
J. 25:713–726. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
McGough A, Pope B, Chlu W and Weeds A:
Cofilin changes the twist of F-actin: Implications for actin
filament dynamics and cellular function. J Cell Biol. 138:771–781.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yamaguchi H and Condeelis J: Regulation of
the actin cytoskeleton in cancer cell migration and invasion.
Biochim Biophys Acta. 1773:642–652. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Ohnishi Y, Minamino Y, Kakudo K and Nozaki
M: Resistance of oral squamous cell carcinoma cells to cexuximab is
associated with EGFR insensitivity and enhanced stem cell-like
potency. Oncol Rep. 32:780–786. 2014.PubMed/NCBI
|
